Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.75 USD | -2.02% | -10.81% | +16.23% |
May. 09 | Adverum Biotechnologies, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 30 | HC Wainwright Starts Adverum Biotechnologies With Buy Rating, $30 Price Target | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.23% | 185M | |
+7.52% | 111B | |
+11.38% | 106B | |
-12.64% | 22.24B | |
+0.44% | 21.25B | |
-4.18% | 18.97B | |
-37.85% | 18.52B | |
-8.58% | 16.81B | |
+37.41% | 12.54B | |
-23.95% | 8.09B |
- Stock Market
- Equities
- ADVM Stock
- News Adverum Biotechnologies, Inc.
- Truist Securities Upgrades Adverum Biotechnologies to Buy From Hold, Adjusts Price Target to $4 From $3